Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (1898)	5/9/2003 2:20:32 PM
From: Mike	Respond to of 23958

I just want to suggest one more time for people to take a look at MDCO. This is a one product company with a great product=Angiomax. There is data that is going to be published in the next couple of months on the use of Angiomax for open heart procedures. Currently, the drug is approved for use in angioplasty procedures. Open heart procedures will over double the market that MDCO currently competes in. Worth a good hard look. Good luck and the chart looks good too. Mike

To: Mike who wrote (1898)	5/9/2003 2:22:21 PM
From: Sergio H	Read Replies (3) \| Respond to of 23958

Mike, this is not a trading acct. and each stock is individually managed. The acct. represents a core position and I am sure that everyone, including me, trades the stocks based on technicals and market conditions. I don't think our results are too shabby so we'll keep the methodology intact BTW, A couple of the red ink stocks moved nicely today. CRV on earnings as mentioned earlier and CLTK is now in the green. Now, a good idea might be to figure out why is it that stocks starting with the letter C have underperformed the rest of the folio.